ABC | Volume 110, Nº5, Maio 2018

Artigo Original Salmazo et al Frequência de aterosclerose subclínica em brasileiros infectados pelo HIV Arq Bras Cardiol. 2018; 110(5):402-410 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 26. Koenig W, Löwel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham score - implications for future risk assessment:resultsfroma largecohortstudyinsouthernGermany.Circulation. 2004;109(11):1349-53. doi: 10.1161/01.CIR.0000120707.98922.E3. 27. Anjos T, Domingos H, Lopes F. High-sensitivity C-reactive protein in patients withmetabolic syndrome: comparison between patients with AIDS and the general population. Rev Bras Cardiol. 2012; 25(1):19-25. 28. Lau B, Sharrett AR, Kingsley LA, PostW, Palella FJ, Visscher B, et al. C-reactive protein is amarker for human immunodeficiency virus disease progression. Arch Intern Med. 2006;166(1):64-70. doi: 10.1001/archinte.166.1.64 29. Laurent S, Cockcroft J, Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-605. doi: 10.1093/ eurheartj/ehl254. 30. Mota-GomesMA, Feitosa AM, BrandãoMC, Chaves H. Augmentation index –novopreditorderiscocardiovascular.RevBrasHipertens.2006;13(1):63-4. 31. Nürnberger J, Keflioglu-Scheiber A, Saez A, Wenzel R, Philipp T, Schäfers R. Augmentation index is associated with cardiovascular risk. J Hypertens. 2002;20(12):2407-14. doi: 10.1097/01.hjh.0000045501.82010.fa. 32. Mulders TA, Van den Bogaard B, Bakker A, TripMD, Stroes ES, Van den Born BJ,etal.Arterialstiffness is increased infamilieswithprematurecoronaryartery disease. Heart. 2012;98(6):490-4. doi: 10.1136/heartjnl-2011-300999. 33. Brasil. Ministério da Saúde. Pesquisa deOrçamentos Familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE; 2010. 34. Kroll AF, Sprinz E, Leal SC, Labrêa Mda G, Setúbal S. Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in Porto Alegre, Brazil. Arq Bras Endocrinol Metabol. 2012;56(2):137-41. doi: http://dx.doi . org/10.1590/S0004-27302012000200007. 35. Silva EF, Bassichetto KC, Lewi DS. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients. Arq Bras Cardiol. 2009;93(2):113-8. doi: http://dx.doi.org/10.1590/S0066- 782X2009000800008. 36. Brasil.MinistériodaSaúde.SecretariadeVigilânciaemSaúde.Departamento deDST, Aids eHepatites Virais. Recomendações para Terapia Antirretroviral em Adultos Infectados pelo HIV - Suplemento II. Brasília; 2010. p.1-28. 37. Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave J, et al; Swiss HIV Cohort Study. Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy. AIDS. 2001;15(3):329-34. PMID: 11273212. 38. Kingsley L, Cuervo-Rojas J, Munoz A, Palella F, Post W, Witt M, et al. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: multicenter AIDS cohort study. AIDS. 2008;22(13):1589-99. doi: 10.1097/QAD.0b013e328306a6c5. 39. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV- associated atherosclerosis. AIDS. 2009;23(9):1059-67. doi: 10.1097/ QAD.0b013e32832b514b. 40. Choi A, Li Y, Deeks S, Grunfeld C, Volberding P, Shlipak M. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010;121(5):651-8. doi: 10.1161/ CIRCULATIONAHA.109.898585. 410